Acadia Pharmaceuticals
ACAD
ACAD
246 hedge funds and large institutions have $6.51B invested in Acadia Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 88 increasing their positions, 83 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% less call options, than puts
Call options by funds: $39.8M | Put options by funds: $40.3M
10% less funds holding
Funds holding: 273 → 246 (-27)
41% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 59
Holders
246
Holding in Top 10
7
Calls
$39.8M
Puts
$40.3M
Top Buyers
| 1 | +$94.2M | |
| 2 | +$62.9M | |
| 3 | +$57.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$45.5M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$44.4M |
Top Sellers
| 1 | -$59.7M | |
| 2 | -$40.2M | |
| 3 | -$33.7M | |
| 4 |
Millennium Management
New York
|
-$28.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.7M |